Advances in Cancer Diagnosis: Bio-Electrochemical and Biophysical Characterizations of Cancer Cells

Micromachines (Basel). 2022 Aug 26;13(9):1401. doi: 10.3390/mi13091401.

Abstract

Cancer is a worldwide leading cause of death, and it is projected that newly diagnosed cases globally will reach 27.5 million each year by 2040. Cancers (malignant tumors), unlike benign tumors are characterized by structural and functional dedifferentiation (anaplasia), breaching of the basement membrane, spreading to adjacent tissues (invasiveness), and the capability to spread to distant sites (metastasis). In the cancer biology research field, understanding and characterizing cancer metastasis as well as features of cell death (apoptosis) is considered a technically challenging subject of study and clinically is very critical and necessary. Therefore, in addition to the cytochemical methods traditionally used, novel biophysical and bioelectrochemical techniques (e.g., cyclic voltammetry and electrochemical impedance spectroscopy), atomic force microscopy, and electron microscopic methods are increasingly being deployed to better understand these processes. Implementing those methods at the preclinical level enables the rapid screening of new anticancer drugs with understanding of their central mechanism for cancer therapy. In this review, principles and basic concepts of new techniques suggested for metastasis, and apoptosis examinations for research purposes are introduced, along with examples of each technique. From our recommendations, the privilege of combining the bio-electrochemical and biosensing techniques with the conventional cytochemical methods either for research or for biomedical diagnosis should be emphasized.

Keywords: apoptosis; atomic force microscopy; cancer biology; electrochemical biosensors; electron microscopy; in-vitro assessment; metastasis.

Publication types

  • Review

Grants and funding

This article is supported by the research project (Multiplex Nano-biosensor for the rapid breast cancer biomarkers detection and anti-cancer agents screening. Project ID: 46218, Applied science, call 1). This research project is funded by the Science, Technology & Innovation Funding Authority (STDF, Cairo, Egypt).